EcoDrugPlus

Somatostatin Receptor 2

Ensembl ID : ENSAMXG00000024982
Gene Symbol: SSTR2
1 Cross references
191 Possible Orthologues:

Somatostatin Receptor 2

Ensembl ID : ENSAMXG00000039332
Gene Symbol: SSTR2
1 Cross references
191 Possible Orthologues:

Somatostatin Receptor 2

Ensembl ID : ENSAMXG00000025985
Gene Symbol: SSTR2
3 Cross references
192 Possible Orthologues:

Somatostatin Receptor Type 5-Like

Ensembl ID : ENSAMXG00000025550
Gene Symbol: LOC103034757
2 Cross references
187 Possible Orthologues:

Sphingosine Kinase 2-Like

Ensembl ID : ENSAMXG00000012399
Gene Symbol: LOC103043132
2 Cross references
203 Possible Orthologues:

Spleen Tyrosine Kinase

Ensembl ID : ENSAMXG00000036960
Gene Symbol: SYK
1 Cross references
203 Possible Orthologues:

Steroid 17-Alpha-Hydroxylase/17,20 Lyase

Ensembl ID : ENSAMXG00000012029
Gene Symbol: LOC103036160
3 Cross references
211 Possible Orthologues:

Steroid 5 Alpha-Reductase 2

Ensembl ID : ENSAMXG00000031911
Gene Symbol: SRD5A2
3 Cross references
208 Possible Orthologues:

Sterol O-Acyltransferase 1

Ensembl ID : ENSAMXG00000013993
Gene Symbol: SOAT1
1 Cross references
210 Possible Orthologues:

Sterol O-Acyltransferase 1

Ensembl ID : ENSAMXG00000039298
Gene Symbol: SOAT1
1 Cross references
210 Possible Orthologues:

Substance-P Receptor-Like

Ensembl ID : ENSAMXG00000042960
Gene Symbol: LOC103042892
3 Cross references
194 Possible Orthologues:

Synaptic Vesicular Amine Transporter

Ensembl ID : ENSAMXG00000016331
Gene Symbol: LOC103032219
3 Cross references
224 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).